Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Cell-Free and Concentrated Ascites Reinfusion Therapy for Malignant Intractable Ascites from Colorectal Cancer]Katsuya Ohta, Masakazu Ikenaga, Masami Ueda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[A Case of Pancreas Neuroendocrine Carcinoma Achieved Long-Term Survival by Carboplatin plus Etoposide Therapy]Toshimasa Okada, Yosuke Katada, Shuji Kitagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2012
[Long-term survival of a case of advanced cancer of the esophagogastric junction with complete response to low-dose 5-fluorouracil and cisplatin chemotherapy]Shinsuke Nakashima, Nobutaka Hatanaka, Yukinobu Yoshikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 3, 2023
[Long-Term Survival following Multidisciplinary Therapy for Unresectable Pancreatic Body Cancer]Shumei Mineta, Toshimasa Okada, Fumiaki Sanuki, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2024
Prospective single-arm multicenter interventional study of surgical resection for liver metastasis from gastric cancer; 3-year overall and recurrence-free survivalKazumasa Fujitani, Yukinori Kurokawa, Ryohei Wada, et al.
The American Surgeon|September 9, 2023
Long-Term Outcomes of Pylorus-Preserving Gastrectomy for Early Gastric CancerYurina Saito, Tsuyoshi Takahashi, Toshirou Nishida, et al.
International Journal of Clinical Oncology|June 5, 2020
Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trialsHisato Kawakami, Kazumasa Fujitani, Jin Matsuyama, et al.
Lancet (London, England)|October 1, 2013
Subcuticular sutures versus staples for skin closure after open gastrointestinal surgery: a phase 3, multicentre, open-label, randomised controlled trialToshimasa Tsujinaka, Kazuyoshi Yamamoto, Junya Fujita, et al.
Annals of Gastroenterological Surgery|November 10, 2021
Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S-1 chemotherapy after gastrectomy: A multicenter, open-label, single-arm, prospective phase II study (OGSG1108)Hiroshi Imamura, Jin Matsuyama, Kazuhiro Nishikawa, et al.
Anticancer Research|March 4, 2025
A Phase II Trial of Trastuzumab Combined With Irinotecan in Patients With Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203 HERBIS-5): Final ResultsJunji Kawada, Daisuke Sakai, Yutaka Kimura, et al.
Pageof 11